Home
Clinical Trials
NCT03763604

Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer

Last Updated: 2024-12-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

APPROVED_FOR_MARKETING

Study Classification

EXPANDED_ACCESS

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The treating physician/investigator contacts Lilly when, based on their medical opinion, a patient meets the criteria for inclusion in the expanded access program.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metastatic Breast Cancer

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Abemaciclib

Administered orally.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

LY2835219

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with hormone receptor positive metastatic breast cancer for whom there is reasonable expectation that abemaciclib may provide clinical benefit and who are suitable to receive abemaciclib.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Liverpool Hospital

Liverpool, New South Wales, Australia

Site Status

North West Cancer Centre

North Tamworth, New South Wales, Australia

Site Status

St Vincent's Hospital Sydney

Sydney, New South Wales, Australia

Site Status

Mater Hospital Sydney

Sydney, New South Wales, Australia

Site Status

Westmead Hospital

Westmead, New South Wales, Australia

Site Status

Wollongong Hospital

Wollongong, New South Wales, Australia

Site Status

Royal Adelaide Hospital

Adelaide, South Australia, Australia

Site Status

Adelaide Oncology and Haematology, Calvary Central Districts Hospital

Elizabeth Vale, South Australia, Australia

Site Status

Icon Cancer Centre - Hobart

Hobart, Tasmania, Australia

Site Status

Royal Hobart Hospital

Hobart, Tasmania, Australia

Site Status

Box Hill Hospital Outpatients

Box Hill, Victoria, Australia

Site Status

Epworth Eastern Hospital

Box Hill, Victoria, Australia

Site Status

Melbourne Cancer Care

Brighton, Victoria, Australia

Site Status

Peter MacCallum Cancer Centre

Melbourne, Victoria, Australia

Site Status

Dr. Zimet Private Room

Richmond, Victoria, Australia

Site Status

Slade Pharmacy Epworth Hospital

Richmond, Victoria, Australia

Site Status

Goulburn Valley Health

Shepparton, Victoria, Australia

Site Status

Icon Cancer Care - The Wesley Medical Centre

Auchenflower, , Australia

Site Status

Northern Beaches Hospital

Freches Forest, , Australia

Site Status

South Coast District Hospital

Victor Harbor, , Australia

Site Status

Tom Baker Cancer Center

Calgary, Alberta, Canada

Site Status

Cross Cancer Institute

Edmonton, Alberta, Canada

Site Status

BC Cancer Vancouver

Vancouver, British Columbia, Canada

Site Status

British Columbia Cancer Agency - Vancouver Island

Victoria, British Columbia, Canada

Site Status

Grand River Regional Cancer Centre

Kitchener, Ontario, Canada

Site Status

The Ottawa Hospital

Ottawa, Ontario, Canada

Site Status

Algoma District Cancer Program

Sault Ste. Marie, Ontario, Canada

Site Status

Unity Health Toronto, St. Michael's Hospital

Toronto, Ontario, Canada

Site Status

CHUL du CHU de Québec

Québec, Quebec, Canada

Site Status

Allan Blair Cancer Centre

Regina, Saskatchewan, Canada

Site Status

Saskatoon Cancer Centre

Saskatoon, Saskatchewan, Canada

Site Status

Cairo Oncology Center (Cairo Cure)

Mohandeseen, Cairo Governorate, Egypt

Site Status

Apollo Cancer Institute, Apollo Speciality Hospital

Teynampet, Chennai, India

Site Status

Indraprastha Apollo Hospital

New Delhi, , India

Site Status

Azienda Ospedaliera Universitaria Policlinico Tor Vergata

Torre, Roma, Italy

Site Status

Istituto Oncologico Veneto IRCCS

Padua, Veneto, Italy

Site Status

Ospedale Di Circolo E Fondazione Macchi

Varese, , Italy

Site Status

Pantai Hospital Sungai Petani

Sungai Petani, Kedah, Malaysia

Site Status

Pantai Hospital Kuala Lumpur

Kuala Lumpur, Kuala Lumpur, Malaysia

Site Status

Beacon Hospital

Off Jalan Templer, Petaling JAYA, Malaysia

Site Status

Pantai Hospital Penang

Bayan BARU, Pulau Pinang, Malaysia

Site Status

Gleneagles Penang

George Town, Pulau Pinang, Malaysia

Site Status

Loh Guan Lye Specialists' Centre

George Town, Pulau Pinang, Malaysia

Site Status

Penang Adventist Hospital

George Town, Pulau Pinang, Malaysia

Site Status

Mount Miriam Cancer Hospital

Tanjung Bungah, Pulau Pinang, Malaysia

Site Status

Hospital Umum Sarawak

Kuching, Sarawak, Malaysia

Site Status

Subang Jaya Medical Centre

Petaling Jaya, Selangor, Malaysia

Site Status

Hospital Kuala Lumpur

Kuala Lumpur, , Malaysia

Site Status

Universiti Malaya Medical Centre

Kuala Lumpur, , Malaysia

Site Status

University Malaya Medical Centre

Kuala Lumpur, , Malaysia

Site Status

Institut Kanser Negara

Putrajaya, , Malaysia

Site Status

Elizabeth Au Oncology

Singapore, , Singapore

Site Status

Vincent Pallotti Hospital

Pinelands, Cape Town, South Africa

Site Status